v3.25.1
Consolidated statement of comprehensive income/(expense) - EUR (€)
€ in Millions
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Consolidated statement of comprehensive income/(expense)      
(Loss)/profit for the financial year € (3,746) € 1,505 € 12,335
Items that may be reclassified to the income statement in subsequent years:      
Foreign exchange translation differences, net of tax 321 (440) (1,236)
Foreign exchange translation differences, transferred to the income statement 115 23 (334)
Other, net of tax [1] 36 (1,748) 963
Total items that may be reclassified to the income statement in subsequent years 472 (2,165) (607)
Items that will not be reclassified to the income statement in subsequent years:      
Fair value gains on equity instruments classified as Other investments, net of tax 116 0 0
Net actuarial gains/(losses) on defined benefit pension schemes, net of tax 1 (58) (160)
Total items that will not be reclassified to the income statement in subsequent years 117 (58) (160)
Other comprehensive (expense)/income 589 (2,223) (767)
Total comprehensive (expense)/income for the financial year (3,157) (718) 11,568
Attributable to:      
- Owners of the parent (3,485) (920) 11,267
- Non-controlling interests 328 202 301
Total comprehensive (expense)/income for the financial year € (3,157) € (718) € 11,568
[1] Principally includes the impact of the Group’s cash flow hedges deferred to other comprehensive income during the year.